LGALS3 and idiopathic pulmonary fibrosis: Gal‐3 was prioritized over other macrophage markers due to its dual role in inflammation and fibrosis, with direct links to IPF progression (Bouffette et al., 2023; Hadjicharalambous & Lindsay, 2020).